What is meant by 'washout' in the context of intraoperative parathyroid hormone (PTH) monitoring for an adult patient with primary hyperparathyroidism due to a parathyroid adenoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is "Washout" in Intraoperative PTH Monitoring

"Washout" refers to the clearance of PTH from the circulation after removal of hyperfunctioning parathyroid tissue, measured by the rapid decline in PTH levels due to its short half-life of only several minutes. 1

Physiologic Basis of Washout

The concept of washout is based on the biological half-life of PTH:

  • PTH has a half-life of only several minutes, which allows for rapid clearance from the bloodstream once the source of excess PTH production is removed 1
  • After successful resection of a parathyroid adenoma, PTH concentration drops instantly because the hyperfunctioning tissue is no longer secreting hormone 1
  • This rapid decline provides surgeons with real-time feedback about whether the diseased parathyroid tissue has been adequately removed 1

Clinical Application During Surgery

The standard criterion for successful washout is a ≥50% decline in PTH compared to the preoperative level, which defines treatment success during parathyroidectomy 1, 2

Timing of Washout Assessment

  • PTH measurements are typically obtained at 5 and 10 minutes after adenoma removal to assess for adequate washout 3
  • With third-generation PTH assays, the washout drop can be observed after 10 minutes, whereas second-generation assays require an additional 30 minutes to demonstrate the same decline 1, 2
  • The faster washout detection with third-generation assays occurs because they measure primarily intact PTH rather than C-terminal fragments, which have longer half-lives 1

Assay-Specific Considerations

The type of PTH assay used significantly impacts washout assessment:

  • Second-generation assays recognize C-terminal fragments that have a longer half-life, making the washout appear slower 1
  • Third-generation assays show a more rapid decrease in PTH concentrations because they don't measure these longer-lived fragments 1, 2
  • The difference is more pronounced in patients with secondary hyperparathyroidism (SHPT) compared to primary hyperparathyroidism (PHPT) 1

Clinical Pitfalls

A common pitfall is removing the wrong gland and misinterpreting inadequate washout: In one reported case, PTH levels remained high after excision of a preoperatively localized lesion, which turned out to be a normal parathyroid gland rather than the adenoma—continued exploration revealed a contralateral adenoma, and subsequent PTH measurement showed proper washout 3

Residual PTH secretion from suppressed normal glands can complicate interpretation: Normal-sized parathyroid glands associated with an adenoma are not completely suppressed and continue to secrete PTH, particularly amino-terminal PTH fragments, which can affect the washout pattern 4

Related Questions

What is the management approach for an adult patient with primary hyperparathyroidism due to a parathyroid adenoma, particularly in regards to intraoperative parathyroid hormone (PTH) washout and post-operative care to prevent complications of hyperparathyroidism?
What is the treatment plan for a patient with asymptomatic hypercalcemia and elevated intact parathyroid hormone (iPTH) level, confirmed parathyroid adenoma on sestamibi scan?
What is the ICD-10 (International Classification of Diseases, 10th Revision) code for a Primary Care Physician (PCP) referral to endocrinology due to a history of parathyroid adenoma?
What is the treatment for parathyroid adenoma?
What is the most appropriate next step in management for a patient with primary hyperparathyroidism, presenting with fatigue, recurrent ureteric stones, bone pain, and a confirmed 2cm parathyroid adenoma, with hypercalcemia (calcium level: 3.50 mmol/L) and no symptoms of polyuria, polydipsia, or central nervous system (CNS) involvement?
What is the recommended dose of paracetamol (acetaminophen) for a 9-year-old child weighing 35 kg?
What are the management options for a patient with pityriasis (P.) rosea?
What are the prevention measures for Nipah virus infection?
What is the role of magnesium sulfate (MgSO4) in fetal neuroprotection for pregnant women at risk of preterm delivery?
What is the onset time of cyclobenzaprine in an adult patient with acute musculoskeletal conditions?
What is the recommended dose of co-amoxiclav (amoxicillin/clavulanic acid) for a 9-year-old child weighing 35 kg with a suspected bacterial infection and no known allergies to penicillin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.